Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2023
Should insurance cover Wegovy, Ozempic and other new weight loss drugs?
16 October 2023 - Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not ...
Posted by Michael Wonder on 09 Oct 2023
Who profits most from America’s baffling health care system?
8 October 2023 - Hint: it isn’t big pharma. ...
Posted by Michael Wonder on 26 Sep 2023
Medicare Advantage and Medicare prescription drug programs to remain stable in 2024
26 September 2023 - Today, the Centers for Medicare & Medicaid Services announced that average premiums, benefits, and plan choices for ...
Posted by Michael Wonder on 02 Sep 2023
Why you cannot win with private health insurance, thanks to a 50 year old quirk
1 September 2023 - In a dimly lit room, a masseur performs an incantation in a baritone voice, slapping fish ...
Posted by Michael Wonder on 24 Aug 2023
CVS Health launches company to produce cheaper ‘biosimilar’ versions of expensive biotech drug
24 August 2023 - CVS Health is launching a new company that will work directly with drug makers to produce ...
Posted by Michael Wonder on 19 Aug 2023
Blue Shield of California looks to cut reliance on CVS, taps Amazon
17 August 2023 - Blue Shield of California plans to stop using most of CVS Health's pharmacy benefit management services ...
Posted by Michael Wonder on 09 Aug 2023
Insurers can’t avoid covering weight loss drugs forever
8 August 2023 - New data illustrating the health benefits of Novo Nordisk’s obesity drug Wegovy puts insurers in the increasingly ...
Posted by Michael Wonder on 05 Aug 2023
Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle
3 August 2023 - Patients are bracing for “D-Day,” the date their insurance companies will stop covering the drugs. Doctors ...
Posted by Michael Wonder on 25 Jul 2023
Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen'
25 July 2023 - Cheaper versions of one of the most costly and widely used arthritis treatments in the US ...
Posted by Michael Wonder on 23 Jul 2023
The consequences and future of prior authorisation reform
22 July 2023 - A proposed rule would require implementation of electronic prior authorisation for health care services among most public ...
Posted by Michael Wonder on 17 Jul 2023
Novel Alzheimer disease treatments and reconsideration of US pharmaceutical reimbursement policy
17 July 2023 - While donanemab appears to be among the first therapies to demonstrate measurable clinical benefit for Alzheimer's disease, ...
Posted by Michael Wonder on 31 May 2023
Insurers call for reform to allow hospital in the home for patients
31 May 2023 - Private insurers are calling for structural reform of the health system to enable more patients to ...
Posted by Michael Wonder on 06 Feb 2023
Annual private health insurance premium rise
6 February 2023 - The Australian Government is ensuring Australians get value for money from their private health insurance as the ...
Posted by Michael Wonder on 24 Jan 2023
Private insurance can contribute to a healthier system
24 January 2023 - Given what many describe as a crisis in primary care, it’s well past time to revisit the ...
Posted by Michael Wonder on 23 Jan 2023
Calls to allow private health insurance to cover fee gaps
24 January 2023 - Health funds are pushing to be able to cover doctors’ gap fees as part of national ...